Commence pivotal Phase 2 trials of CYNK-001
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Jan 2021
- Due
- 31 Dec 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Celularity plans to commence pivotal Phase 2 trials of CYNK-001 for the treatment of both AML and GBM in 2021.”
What we found
Evidence strength A What the grades mean
The company did not commence pivotal Phase 2 trials for CYNK-001 in 2021; filings indicate the program remained in Phase 1 or Phase 1/2a stages during and after that period.
-
A GX Acquisition Corp. 10-K filed 2023-03-31
“In the fourth quarter of 2021, we initiated a Phase 1 dose escalation trial in recurrent GBM” ✓ confirmed on the page
-
A GX Acquisition Corp. 10-K filed 2022-03-31
“CYNK-001 is currently in Phase 1 trial for AML and a Phase 1/2a trial for GBM, respectively.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Project other
- Indicative materiality
- Low rules
- Action
- Commence
- Deliverable
- CYNK-001 pivotal Phase 2 trials
- Target
- 2 trials
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you GX Acquisition Corp.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CELU-021378 · Corrections policy